AITbiotech Launches Detection Kit for Novel Coronavirus COVID-19
New highly sensitive test offers results in a fraction of the time compared to current CDC detection methods
AITbiotech has just released a qPCR detection kit for the novel coronavirus COVID-19, enabling highly accurate detection of the new virus strand in just 90 minutes.
The rapid test, which is compatible with AITbiotech’s abCyclerQ platform, as well as Bio-Rad CFX96™ and Applied Biosystems® 7500 Fast; offers global government institutions and public healthcare facilities a commercialized, reliable and time-saving detection solution to aid in effectively monitoring and controlling the current COVID-19 outbreak.
The kit, abTES™ COVID-19 qPCR I Kit, has been evaluated with positive sample materials and selectively identifies the new COVID-19 virus. It is already in full production at AITbiotech’s Singapore facilities and available for order from qualifying laboratories.
COVID-19 is a new strain of coronavirus that was first reported from Wuhan, China on 31 December 2019. Coronaviruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Currently, there is no human vaccine on the market which protects against COVID-19. More detailed information on the COVID-19 outbreak is available on http://www.who.int/.
Established in Singapore since 2006, AITbiotech Pte Ltd is an ISO 13485 certified biotechnology company that develop, manufacture and supply Singapore-branded molecular diagnostic and genomic products for the international market. Its products are now sold in more than a dozen Asian countries. Apart from having a core team of experienced biotechnologists for in-house development, AITbiotech also works very closely with local scientific and medical experts such as A*STAR and NUS. AITbiotech is the first Southeast Asian company to commercialize multiplex real-time PCR assays under the brand abTES™ for the detection of pathogens such as influenza, dengue, chikungunya, zika and malaria. As part of the company’s vision to provide a complete portfolio for molecular diagnostic solutions, it has its own range of instrumentation for nucleic acid extraction, PCR and real-time PCR, as well as their accompanying reagent and consumables. It is also the distributor of other life science products in Singapore including Eppendorf and New England Biolabs instruments and reagents.
For more information, please visit our website: www.aitbiotech.com.
Sales & Media Contact
Mr. Will Chiang
AITbiotech Pte Ltd
+65 9169 6757